Archives
Niclosamide: From Pathway Hit to Assay Evidence
2026-09-07
Niclosamide research is strongest when pathway inhibition, cell-cycle arrest, and cell death are measured separately. This evidence-centered guide combines product chemistry with dissertation insights to improve assay design and interpretation in cancer research.
LY2109761 for TGF-β Signaling Workflows
2026-09-05
LY2109761 provides a practical way to interrogate receptor-proximal TGF-β signaling in cancer, radiation, and fibrosis models. This guide connects inhibition of Smad2/3 phosphorylation with reproducible cell-based workflows, formulation controls, and evidence-aware assay design.
ERK5 in Vitamin D–Induced Myeloid Leukemia Differentiation
2026-09-04
Wang et al. distinguished the roles of the ERK5 and ERK1/2 branches of MAPK signaling during 1α,25-dihydroxyvitamin D3-induced differentiation of HL60 and U937 myeloid leukemia cells. Their results show that ERK5 inhibition alters lineage-marker expression while producing cell-cycle arrest in both G1 and G2, whereas MEK1/2 inhibition with PD98059 or U0126 broadly suppresses differentiation markers.
Dynamic LRIG1 Expression in Salivary Gland Development
2026-09-04
This study combines single-cell RNA sequencing with histological and in vitro analyses to define how LRIG1 distribution changes during murine submandibular gland development. The findings place LRIG1 in epithelial, mesenchymal, acinar, and basal progenitor-associated compartments, providing a framework for studying salivary gland homeostasis and regeneration.
Acetoacetic Acid Sodium Salt: Assay Design Guide
2026-09-03
Acetoacetic acid sodium salt is more than a ketone-body substrate: it is a controlled probe for separating fatty acid catabolism from assay artifacts. This guide combines metabolic interpretation, physicochemical controls, and lessons from isotope-standard development for more rigorous diabetes metabolic imbalance research.
Tunneling Nanotubes Transport KRas in Tumors
2026-09-03
The reference study shows that tunneling nanotubes can transfer mutant KRas between tumor cells, linking intercellular oncogene exchange with reduced membrane tension and faster phospholipid flow. Its combined confocal fluorescence, optical-tweezer, and gene-interference approach provides a mechanistic framework for understanding how tumor heterogeneity may acquire a mechanically invasive phenotype.
BMN 673 for DNA Repair Deficiency Research
2026-09-02
BMN 673 (Talazoparib) combines subnanomolar PARP1/2 inhibition with strong PARP-DNA complex trapping, making it a precise tool for testing DNA repair vulnerabilities. This workflow connects spliceosome biology, homologous recombination status, and response profiling in HCC, SCLC, and other translational cancer models.
DFCP1 Controls ATGL Lipolysis in Starved Cells
2026-09-02
The reference study identifies DFCP1/ZFYVE1 as a nutrient-sensitive regulator of lipid droplet catabolism. Rather than simply activating ATGL, DFCP1 recruits the lipase to lipid droplets while limiting its dynamic exchange, thereby restraining starvation-driven lipolysis and refining models of lipid mobilization.
L-Phenylephrine in α1A Receptor Research
2026-09-01
L-Phenylephrine is an adrenergic α1A receptor agonist used to study α1-adrenergic receptor signaling, vasoconstriction, cardiomyocyte stress responses, and neural progenitor biology. Product evidence and a peer-reviewed mouse study support its value as a mechanistic research tool, but they do not establish a therapeutic use for sex-specific hypertension.
ML216: BLM Helicase Inhibition in Cancer Assays
2026-09-01
ML216 is a BLM helicase inhibitor for dissecting DNA repair dependencies, replication stress, and tumor cell sensitization to chemotherapy. This article explains how to distinguish BLM-specific activity from broader RecQ helicase effects and translate biochemical, cellular, and xenograft findings into rigorous assay decisions.
Human PSC Teratomas Reveal Skeletal Myogenic Lineage
2026-08-31
Pappas and colleagues show that human pluripotent stem cell-derived teratomas generate skeletal myogenic progenitors spanning developmental stages that resemble embryonic human myogenesis. Single-cell transcriptomics and surface-marker analysis identify ERBB3 and CD82 as useful candidates for prospective isolation, establishing teratomas as an accessible platform for studying and obtaining human muscle progenitors.
LLY-507: Selective SMYD2 Inhibitor Workflows
2026-08-31
LLY-507 combines sub-15 nM biochemical potency with strong target selectivity, making it useful for connecting SMYD2 methyltransferase activity to cancer-cell phenotypes. This guide translates the compound into practical methylation, proliferation, apoptosis, and renal-fibrosis assay workflows while emphasizing controls and interpretation limits.
GS967 for Cardiac Late Sodium Current Studies
2026-08-30
GS967 is a cardiac late sodium current inhibitor designed to separate pathological late Na⁺ influx from broader conduction effects. Its concentration-dependent activity supports workflows spanning in vitro cardiac electrophysiology, ventricular myocyte sodium current inhibition, and ex vivo arrhythmia prevention research.
LLY-507: Reading SMYD2 Biology Across Models
2026-08-29
LLY-507 is a selective SMYD2 inhibitor for dissecting methyltransferase-dependent signaling in cancer and tissue injury. This article presents a model-to-assay framework that separates biochemical potency, cellular target engagement, phenotype, and translational evidence.
Mtb–BMX Signaling Rewires Lysosomal Acidification
2026-08-28
The reference study identifies a host–pathogen mechanism in which M. tuberculosis Chp2/Rv1184 promotes BMX-dependent phosphorylation of ATP6V1E1, disrupting V-ATPase assembly and lysosomal acidification. The findings connect a secreted mycobacterial protein to a specific host kinase pathway and support further evaluation of BMX and lysosomal acidification as host-directed tuberculosis targets.
689 records 6/46 page Previous Next First page 上5页 678910 下5页 Last page